MiR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27

被引:0
|
作者
Yong Yang
Yan Bao
Guo-Kai Yang
Jia Wan
Ling-Juan Du
Zhen-Huan Ma
机构
[1] The Second People’s Hospital of Yunnan Province,The Third Department of General Surgery
[2] The Fourth Affiliated Hospital of Kunming MedicalUniversity,Department of Vascular Surgery
来源
关键词
miR-214; Hsp27; 3′-UTR; 5-FU; Colon cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Overcoming chemorestistance to 5-fluorouracil (5-FU) could offer a new treatment option for highly malignant colon cancer. In our study, differential microRNA expression profiling revealed that miR-214 is downregulated in 5-FU-resistant colon cancer cells compared to normal cells. In vitro, miR-214 could sensitize non-resistant colon cancer cells and 5-FU-resistant colon cancer cellsto 5-FU. Functionally, miR-214 inhibited cell clone formation and cell growth and enhanced 5-FU-inducing cell apoptosis and caspase-3 levels. MiR-214 targeted heat shock protein 27 (Hsp27), as confirmed via dual luciferase reporter assays and western blots. Hsp27 also sensitized HT-29 and LoVo to 5-FU by enhancing cell apoptosis. Overexpression of Hsp27 could block miR-214 with an effect on the sensitivity of colon cancer cells to 5-FU. In conclusion, miR-214 sensitizes colon cancer cells to 5-FU by targeting Hsp27, indicating a significant role for this miRNA in colon cancer chemotherapy.
引用
收藏
相关论文
共 50 条
  • [31] Expression of miR-214 and RASSF5 in oral cancer patients and their effects on apoptosis of oral cancer cells
    Deng, Na
    Xu, Jinsong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11579 - 11586
  • [32] MiR-200c sensitizes colorectal cancer cells to 5-FU through Bcl-2-involved apoptotic pathway
    Qian, Xuemin
    Howell, Paul
    Li, Xiaobo
    Qin, Xin
    Gao, Lin
    Xi, Yaguang
    CANCER RESEARCH, 2010, 70
  • [33] MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells
    Wang, C-Q
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (09) : 3771 - 3778
  • [34] LncRNA BDNF-AS inhibits proliferation, migration, invasion and EMT in oesophageal cancer cells by targeting miR-214
    Zhao, Huaying
    Diao, Changying
    Wang, Xiaohui
    Xie, Yilin
    Liu, Yaqing
    Gao, Xianzheng
    Han, Jing
    Li, Shenglei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (08) : 3729 - 3739
  • [35] The inhibitory role of miR-214 in cervical cancer cells through directly targeting mitochondrial transcription factor A (TFAM)
    Wen, Z.
    Lei, Z.
    Jin-An, M.
    Xue-Zhen, L.
    Xing-Nan, Z.
    Xiu-Wen, D.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (06) : 676 - 682
  • [36] Basal regulatory promoter elements of the hsp27 gene in human breast cancer cells
    Oesterreich, S
    Hickey, E
    Weber, LA
    Fuqua, SAW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 222 (01) : 155 - 163
  • [37] Hsp27 overexpression inhibits doxorubicin–induced apoptosis in human breast cancer cells
    Rhonda K. Hansen
    Irma Parra
    Pierre Lemieux
    Steffi Oesterreich
    Susan G. Hilsenbeck
    Suzanne A. W. Fuqua
    Breast Cancer Research and Treatment, 1999, 56 (2) : 185 - 194
  • [38] Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo
    He, Jinxia
    Xie, Ganfeng
    Tong, Jingtao
    Peng, Yonghai
    Huang, Haihui
    Li, Jianjun
    Wang, Ning
    Liang, Houjie
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2014, 70 (02) : 1343 - 1350
  • [39] Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo
    Jinxia He
    Ganfeng Xie
    Jingtao Tong
    Yonghai Peng
    Haihui Huang
    Jianjun Li
    Ning Wang
    Houjie Liang
    Cell Biochemistry and Biophysics, 2014, 70 : 1343 - 1350
  • [40] MiR-3074-5p suppresses non-small cell lung cancer progression by targeting the YWHAZ/Hsp27 axis
    Dong, Nian
    Gu, Wen-Wen
    Yang, Long
    Lian, Wen-Bo
    Jiang, Juan
    Zhu, Hai-Jun
    Chen, Cheng-Shui
    Wang, Bei-Bei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 138